z-logo
open-access-imgOpen Access
Apolipoprotein CIII promotes Ca 2+ -dependent β cell death in type 1 diabetes
Author(s) -
Lisa JunttiBerggren,
Essam Refai,
Ioulia B. Appelskog,
Mats Andersson,
Gabriela Imreh,
Nancy Dekki,
Sabine Uhles,
Lina Yu,
William J. Griffiths,
С. В. Зайцев,
Ingo B. Leibiger,
Shao-Nian Yang,
Gunilla Olivecrona,
Hans Jörnvall,
PerOlof Berggren
Publication year - 2004
Publication title -
proceedings of the national academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.011
H-Index - 771
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.0403551101
Subject(s) - type 2 diabetes , apolipoprotein b , chemistry , diabetes mellitus , biology , medicine , endocrinology , biochemistry , cholesterol
In type 1 diabetes (T1D), there is a specific destruction of the insulin secreting pancreatic beta cell. Although the exact molecular mechanisms underlying beta cell destruction are not known, sera from T1D patients have been shown to promote Ca(2+)-induced apoptosis. We now demonstrate that apolipoprotein CIII (apoCIII) is increased in serum from T1D patients and that this serum factor both induces increased cytoplasmic free intracellular Ca(2+) concentration ([Ca(2+)](i)) and beta cell death. The apoCIII-induced increase in [Ca(2+)](i) reflects an activation of the voltage-gated L-type Ca(2+) channel. Both the effects of T1D sera and apoCIII on the beta cell are abolished in the presence of antibody against apoCIII. Increased serum levels of apoCIII can thus account for the increase in beta cell [Ca(2+)](i) and thereby beta cell apoptosis associated with T1D.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom